Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery
about
Ectopic expression of KCNE3 accelerates cardiac repolarization and abbreviates the QT intervalPreservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarctionBeta-Adrenergic gene therapy for cardiovascular diseaseGene therapy targets in heart failure: the path to translationTargeted inhibition of calcineurin attenuates cardiac hypertrophy in vivoβ2-adrenoceptor transfection enhances contractile reserve of isolated rat ventricular myocytes exposed to chronic isoprenaline stimulation by improving β1-adrenoceptor responsivenessGene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications.Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through beta 2-adrenoceptors.Cardiac gene therapy: optimization of gene delivery techniques in vivo.Cardiac gene therapyGenetic manipulation of beta-adrenergic signalling in heart failure.Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?Rescuing the failing heart by targeted gene transferTargeting calcium cycling proteins in heart failure through gene transfer.Emerging therapeutic targets in chronic heart failure: part II.Targeting signaling pathways in heart failure by gene transfer.Gene therapy for heart failure.The evolution of heart gene delivery vectorsTargeted high-efficiency, homogeneous myocardial gene transfer.Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy.Myocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure.Potential of gene therapy as a treatment for heart failureVentricular-assist devices for the treatment of chronic heart failure.Current strategies for myocardial gene delivery.Gene therapy in heart failure.Designing heart performance by gene transfer.Gene therapy to treat cardiovascular disease.Cardiac gene therapy with SERCA2a: from bench to bedsideCardiac gene therapy: from concept to reality.Lentiviral vectors and cardiovascular diseases: a genetic tool for manipulating cardiomyocyte differentiation and function.Gene therapy for heart failure: where do we stand?Percutaneous approaches for efficient cardiac gene delivery.Therapeutic potential of genes in cardiac repair.Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.Cardiac gene therapy: are we there yet?Emerging therapies for heart failure.Left ventricular targeting of reporter gene expression in vivo by human BNP promoter in an adenoviral vector.Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model.Overexpression of beta 1 and beta 2 adrenergic receptors in rat atrial myocytes. Differential coupling to G protein-gated inward rectifier K(+) channels via G(s) and G(i)/o.In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo.
P2860
Q24551736-18591CD9-A9B4-4D20-BDD9-8D3E83D05539Q24656335-C330E7C6-62DE-4EEA-B591-6C682C7BFE8AQ24792845-B251BA6E-5D91-40B7-A516-1B7110F77E57Q27022444-39483EAA-20B8-4313-BBDD-13DBEB3D5612Q28360110-17B6BE45-F309-417B-9F05-EF6EE832CB88Q28573247-16E61FEB-DE01-4E3A-8758-2ED89AFB8A8DQ30427066-C5CE2A2E-8ADE-48BB-9F36-FDE4C82FB097Q33717958-AF3577D5-7C3F-4732-B2D3-398859AC9A8FQ33832137-2646913C-B5B6-4896-A405-281F973EF33FQ34409721-8ACCCEFE-4910-472F-A9D2-3B88A4F6EEE5Q34419016-2953D0C9-CDFB-4C91-8978-F2007DF0FB9FQ34482530-472773C1-C2A6-454A-B44E-6A6EF40E7B55Q34757960-4CF00676-C4A1-4B5D-A926-0766EDBBF94CQ35037546-37688B1C-A3DF-476C-AC5B-90DF32C1DE54Q35056026-1DA714EB-C709-4F8A-85B8-D1D2C6E36FE8Q35095401-FCF7A3CF-C7D0-4ACB-9704-89B920E7B313Q35791499-684C91F4-FAF9-43F9-90EB-153B5670CB37Q35799722-E19A44CF-018C-4292-A78A-6CFBEF9E6BAEQ35990749-5678724D-99C5-415F-B96E-8F2C64C56657Q36014089-145ABD35-7A9E-4AEE-85A6-AFF391F8D8A2Q36252791-9D49FC63-0578-4CA1-BE18-21A54C894D29Q36497159-E953718C-23E2-4249-877F-9518DEB523B6Q36815993-BC4C647B-7BA4-445E-8C69-93223F50BF12Q36931967-EE49E7ED-1DE3-44B4-B0AA-482AF5D71FB9Q36944623-9B20BB12-616C-43D7-96B4-7598E4F5658EQ37299072-229694AA-E2F5-4A25-872D-3598388A0D5CQ37310450-37200F97-0699-431E-953E-0020B0085650Q37811189-E36FB23F-4E1A-41E7-8C2F-B33D1964FEDAQ37965045-FE93CC2F-CE45-4403-8587-65EE4E7512A0Q37989402-F9BB545A-5285-42F6-9D64-FCC666592208Q38073152-60D1F6A1-FFBB-4FAF-9163-42B6E6FF094AQ38113171-7F5CF370-13FB-4B7F-BE15-EC658800EFCEQ38128924-7032476D-08B6-49A7-8078-26F279BDA830Q38132253-320F2195-07B2-4A3F-B178-180E1DAB8F0FQ38820937-EC73DE46-F920-4B14-8022-DC74D54FA238Q40409363-D2814828-0871-437F-A253-C2EB2A0FC99FQ40703867-22369285-1DA0-4A85-9259-FB02103CAB89Q41890749-B160AE33-5C5F-4E81-A84F-BCCD60BC4F33Q43701650-DF7E1086-1069-46B9-8ED5-94205BB99875Q43856052-ACD0415C-FA75-41FC-A5DD-818A2922715A
P2860
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Enhancement of cardiac functio ...... energic receptor gene delivery
@ast
Enhancement of cardiac functio ...... energic receptor gene delivery
@en
type
label
Enhancement of cardiac functio ...... energic receptor gene delivery
@ast
Enhancement of cardiac functio ...... energic receptor gene delivery
@en
prefLabel
Enhancement of cardiac functio ...... energic receptor gene delivery
@ast
Enhancement of cardiac functio ...... energic receptor gene delivery
@en
P2093
P2860
P356
P1476
Enhancement of cardiac functio ...... energic receptor gene delivery
@en
P2093
D D Glower
J P Maurice
K H Wilson
P C Dolber
P H McDonald
R J Lefkowitz
P2860
P356
10.1172/JCI6026
P407
P577
1999-07-01T00:00:00Z